Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Bioengineering
Reference37 articles.
1. Verbruggen, G. (2006). Chondroprotective drugs in degenerative joint diseases. Rheumatology., 45(2), 129–138.
2. Hochberg, M. C., & Dougados, M. (2001). Pharmacological therapy of osteoarthritis. Best Practice & Research Clinical Rheumatology., 15(4), 583–593.
3. Kongtharvonskul, J., Anothaisintawee, T., McEvoy, M., Attia, J., Woratanarat, P., & Thakkinstian, A. (2015). Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: A systematic review and network meta-analysis. European Journal of Medical Research., 20(1), 1–11.
4. Mahajan, A., Singh, K., Tandon, V. R., Kumar, S., & Kumar, H. (2006). Diacerein: A new symptomatic slow acting drug for osteoarthritis. JK Science., 8(3), 173–175.
5. Almezgagi, M., Zhang, Y., Hezam, K., Shamsan, E., Gamah, M., Al-Shaebi, F., et al. (2020). Diacerein: Recent insight into pharmacological activities and molecular pathways. Biomedicine & Pharmacotherapy., 131, 110594.